{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:28:13Z","timestamp":1786980493708,"version":"build-2736575974"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071459"],"award-info":[{"award-number":["82071459"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Institute of Brain science and Brain-inspired technology of West China Hospital","award":["ZYJC21001"],"award-info":[{"award-number":["ZYJC21001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s10072-023-06769-x","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T06:23:20Z","timestamp":1680503000000},"page":"3253-3259","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Patient characteristics and outcome in patients with anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) encephalitis"],"prefix":"10.1007","volume":"44","author":[{"given":"Jingfang","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jierui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7411-8269","authenticated-orcid":false,"given":"Jinmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,3]]},"reference":[{"key":"6769_CR1","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/ana.21589","volume":"65","author":"M Lai","year":"2009","unstructured":"Lai M, Hughes EG, Peng X et al (2009) AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 65:424\u2013434","journal-title":"Ann Neurol"},{"key":"6769_CR2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1212\/WNL.0b013e3181cb3e52","volume":"74","author":"L Bataller","year":"2010","unstructured":"Bataller L, Galiano R, Garcia-Escrig M et al (2010) Reversible paraneoplastic limbic encephalitis associated with antibodies to the AMPA receptor. Neurology 74:265\u2013267","journal-title":"Neurology"},{"key":"6769_CR3","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1212\/WNL.0b013e3181d3e404","volume":"74","author":"F Graus","year":"2010","unstructured":"Graus F, Boronat A, Xifro X et al (2010) The expanding clinical profile of anti-AMPA receptor encephalitis. Neurology 74:857\u2013859","journal-title":"Neurology"},{"key":"6769_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jneuroim.2013.05.011","volume":"261","author":"YC Wei","year":"2013","unstructured":"Wei YC, Liu CH, Lin JJ et al (2013) Rapid progression and brain atrophy in anti-AMPA receptor encephalitis. J Neuroimmunol 261:129\u2013133","journal-title":"J Neuroimmunol"},{"key":"6769_CR5","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1001\/jamaneurol.2015.1715","volume":"72","author":"B Joubert","year":"2015","unstructured":"Joubert B, Kerschen P, Zekeridou A et al (2015) Clinical spectrum of encephalitis associated with antibodies against the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor: case series and review of the literature. JAMA Neurol 72:1163\u20131169","journal-title":"JAMA Neurol"},{"key":"6769_CR6","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1212\/WNL.0000000000001682","volume":"84","author":"R Hoftberger","year":"2015","unstructured":"Hoftberger R, van Sonderen A, Leypoldt F et al (2015) Encephalitis and AMPA receptor antibodies: novel findings in a case series of 22 patients. Neurology 84:2403\u20132412","journal-title":"Neurology"},{"key":"6769_CR7","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","volume":"12","author":"MJ Titulaer","year":"2013","unstructured":"Titulaer MJ, McCracken L, Gabilondo I et al (2013) Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 12:157\u2013165","journal-title":"Lancet Neurol"},{"key":"6769_CR8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s11940-017-0474-1","volume":"19","author":"S Mahajan","year":"2017","unstructured":"Mahajan S, Appleby BS (2017) Comprehensive and methodical: diagnostic and management approaches to rapidly progressive dementia. Curr Treat Options Neurol 19:40","journal-title":"Curr Treat Options Neurol"},{"key":"6769_CR9","doi-asserted-by":"publisher","first-page":"e2546","DOI":"10.1212\/WNL.0000000000011937","volume":"96","author":"GS Day","year":"2021","unstructured":"Day GS, Yarbrough MY, Kortvelyessy P et al (2021) Prospective quantification of CSF biomarkers in antibody-mediated encephalitis. Neurology 96:e2546\u2013e2557","journal-title":"Neurology"},{"issue":"91\u2013105","key":"6769_CR10","volume":"100","author":"H Haselmann","year":"2018","unstructured":"Haselmann H, Mannara F, Werner C et al (2018) Human autoantibodies against the AMPA receptor subunit GluA2 induce receptor reorganization and memory dysfunction. Neuron 100(91\u2013105):e109","journal-title":"Neuron"},{"key":"6769_CR11","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1124\/pr.109.002451","volume":"62","author":"SF Traynelis","year":"2010","unstructured":"Traynelis SF, Wollmuth LP, McBain CJ et al (2010) Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev 62:405\u2013496","journal-title":"Pharmacol Rev"},{"key":"6769_CR12","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00441-006-0275-4","volume":"326","author":"R Sprengel","year":"2006","unstructured":"Sprengel R (2006) Role of AMPA receptors in synaptic plasticity. Cell Tissue Res 326:447\u2013455","journal-title":"Cell Tissue Res"},{"key":"6769_CR13","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/ana.24293","volume":"77","author":"X Peng","year":"2015","unstructured":"Peng X, Hughes EG, Moscato EH et al (2015) Cellular plasticity induced by anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor encephalitis antibodies. Ann Neurol 77:381\u2013398","journal-title":"Ann Neurol"},{"key":"6769_CR14","doi-asserted-by":"publisher","first-page":"652820","DOI":"10.3389\/fimmu.2021.652820","volume":"12","author":"TY Zhang","year":"2021","unstructured":"Zhang TY, Cai MT, Zheng Y et al (2021) Anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor encephalitis: a review. Front Immunol 12:652820","journal-title":"Front Immunol"},{"key":"6769_CR15","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1136\/jnnp-2011-300411","volume":"83","author":"C Finke","year":"2012","unstructured":"Finke C, Kopp UA, Pruss H et al (2012) Cognitive deficits following anti-NMDA receptor encephalitis. J Neurol Neurosurg Psychiatry 83:195\u2013198","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"6769_CR16","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1212\/WNL.0000000000003009","volume":"87","author":"H Arino","year":"2016","unstructured":"Arino H, Armangue T, Petit-Pedrol M et al (2016) Anti-LGI1-associated cognitive impairment: presentation and long-term outcome. Neurology 87:759\u2013765","journal-title":"Neurology"},{"key":"6769_CR17","doi-asserted-by":"publisher","first-page":"577471","DOI":"10.1016\/j.jneuroim.2020.577471","volume":"351","author":"J Lin","year":"2021","unstructured":"Lin J, Li C, Li A et al (2021) Long-term cognitive and neuropsychiatric outcomes of anti-GABABR encephalitis patients: a prospective study. J Neuroimmunol 351:577471","journal-title":"J Neuroimmunol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-06769-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-023-06769-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-06769-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T02:43:28Z","timestamp":1691635408000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-023-06769-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,3]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["6769"],"URL":"https:\/\/doi.org\/10.1007\/s10072-023-06769-x","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,3]]},"assertion":[{"value":"24 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Research Ethics Committee of the West China Hospital of Sichuan University, and written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from the participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}